ARCADIA PHARMA LIMITED
Location
Founded
2013-04-22
Website
Risk Signals
116 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Pharmaceutical Preparations, Drugs, Drug Proprietaries, and Druggists' Sundries), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Corporate Insolvency (23)
Legal Proceedings (16)
Acquisition Announcements (14)
Investment Strategies (7)
Business Launches (6)
Real Estate Events (5)
Inter-Organizational Collaborations (5)
Pension Fund Strategies (4)
Business Growth Initiatives (4)
Market Supply and Demand Shifts (3)
Funding Announcements (3)
Corporate Awards and Recognitions (3)
Research Breakthroughs (3)
Executive Leadership Changes (3)
Competitive Market Dynamics (2)
IT Infrastructure Disruption (2)
Capital Funding Requests (2)
Key Milestones & Anniversaries (2)
Environmental Assessments (2)
Corporate Deals (2)
Asset Divestment (2)
Fraud Investigations (2)
Regulatory and Legal Emergencies (2)
Renewable Energy Innovations (1)
Research and Development (1)
Stock Market Events (1)
Sustainable Practices (1)
Tax Compliance Violations (1)
Tax Policy and Ethics (1)
Tech Innovation & Advancements (1)
Recent Articles about ARCADIA PHARMA LIMITED
Live alerts from global media, monitored by Business Radar
(law360.com)
Watch Out For Sale of Arcadia, MPs Tell Pensions Regulator
A parliamentary committee is to urge the U.K. pensions regulator to be ready to respond following reports that colorful millionaire Sir Philip Green may sell his retail empire, which is burdened with a £565 million ($791 million) pension deficit.
Read more